Diagnostics & Research
The Diagnostics & Research industry has a total of 45 stocks, with a combined market cap of $759.7 billion, total revenue of $168.76 billion and a weighted average PE ratio of 43.43.
Market Cap
759.7B
Revenue
168.76B
Profits
17.49B
PE Ratio
43.43
Profit Margin
10.37%
Dividend Yield
0.22%
45 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 197.88B | -1.97% | 1,476,060 | 45.20B |
| 2 | DHR | Danaher Corporation | 144.26B | -0.58% | 4,965,779 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 44.76B | -1.50% | 535,563 | 4.45B |
| 4 | NTRA | Natera, Inc. | 38.87B | 0.58% | 1,014,400 | 2.50B |
| 5 | A | Agilent Technologies, Inc. | 37.13B | -3.41% | 4,247,314 | 7.23B |
| 6 | WAT | Waters Corporation | 36.23B | -2.44% | 573,587 | 3.77B |
| 7 | IQV | IQVIA Holdings Inc. | 34.42B | -2.01% | 1,262,427 | 16.63B |
| 8 | ILMN | Illumina, Inc. | 28.24B | -1.89% | 1,251,035 | 4.39B |
| 9 | MTD | Mettler-Toledo International Inc. | 26.47B | -1.88% | 131,366 | 4.09B |
| 10 | DGX | Quest Diagnostics Incorporated | 23.32B | 0.61% | 955,493 | 11.28B |
| 11 | LH | Labcorp Holdings Inc. | 23.24B | 0.50% | 631,872 | 14.14B |
| 12 | GH | Guardant Health, Inc. | 20.67B | 0.56% | 1,996,888 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 15.36B | -0.04% | 231,154 | 2.68B |
| 14 | ICLR | ICON Public Limited Company | 13.02B | - | 579,565 | 8.27B |
| 15 | RVTY | Revvity, Inc. | 12.29B | -1.33% | 1,248,949 | 2.90B |
| 16 | CRL | Charles River Laboratories International, Inc. | 10.81B | -2.10% | 710,193 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 8.51B | -0.87% | 2,217,678 | 2.10B |
| 18 | BLLN | BillionToOne, Inc. | 5.99B | 1.66% | 617,989 | 354.54M |
| 19 | TWST | Twist Bioscience Corporation | 5.84B | 2.87% | 1,162,036 | 409.48M |
| 20 | SHC | Sotera Health Company | 5.06B | -2.85% | 3,213,107 | 1.19B |
| 21 | RDNT | RadNet, Inc. | 4.89B | -1.27% | 820,871 | 2.14B |
| 22 | VCYT | Veracyte, Inc. | 4.72B | -0.15% | 2,010,229 | 541.74M |
| 23 | ADPT | Adaptive Biotechnologies Corporation | 3.67B | 3.71% | 3,233,008 | 295.41M |
| 24 | GRAL | GRAIL, Inc. | 3.12B | 0.92% | 413,753 | 156.12M |
| 25 | CDNA | CareDx, Inc. | 2.05B | -1.51% | 1,763,631 | 412.82M |
| 26 | NEO | NeoGenomics, Inc. | 1.90B | -1.55% | 11,034,760 | 745.97M |
| 27 | WGS | GeneDx Holdings Corp. | 1.88B | 2.90% | 521,755 | 442.68M |
| 28 | PSNL | Personalis, Inc. | 1.61B | -1.22% | 6,618,828 | 64.52M |
| 29 | OPK | OPKO Health, Inc. | 898.56M | - | 1,753,203 | 581.12M |
| 30 | CSTL | Castle Biosciences, Inc. | 732.77M | -0.29% | 242,886 | 339.92M |
| 31 | MYGN | Myriad Genetics, Inc. | 583.69M | -0.16% | 734,416 | 829.00M |
| 32 | FLGT | Fulgent Genetics, Inc. | 572.56M | -1.90% | 161,446 | 320.35M |
| 33 | BDSX | Biodesix, Inc. | 209.08M | 1.15% | 40,796 | 96.10M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 153.06M | 0.64% | 39,111 | 1.95M |
| 35 | XGN | Exagen Inc. | 106.06M | 3.29% | 159,897 | 68.38M |
| 36 | BNR | Burning Rock Biotech Limited | 105.15M | 3.75% | 4,132 | 74.58M |
| 37 | PRPO | Precipio, Inc. | 44.04M | 4.05% | 108,324 | 25.83M |
| 38 | MDXH | MDxHealth SA | 21.72M | -0.66% | 312,488 | 110.97M |
| 39 | QUCY | Quantum Cyber N.V. | 18.03M | 3.36% | 727,087 | 537.08K |
| 40 | XWEL | XWELL, Inc. | 9.04M | 1.90% | 24,722 | 28.83M |
| 41 | ADVB | Advanced Biomed Inc. | 8.31M | 2.65% | 2,735,990 | - |
| 42 | MBAI | Check-Cap Ltd. | 7.29M | - | 12,193 | - |
| 43 | NDRA | ENDRA Life Sciences Inc. | 6.34M | -5.31% | 56,476 | - |
| 44 | BIAF | bioAffinity Technologies, Inc. | 3.19M | -1.14% | 75,105 | 5.66M |
| 45 | ISPC | iSpecimen Inc. | 3.02M | -4.98% | 54,601 | 1.03M |